Abiopharma

P3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference Call

Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference

Trevi Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 7, 2025

Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025

Safety Shot Appoints Markita Russell as Chief Financial Officer

Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance

4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update

iRhythm Technologies Announces Second Quarter 2025 Financial Results

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

Envista Reports Second Quarter 2025 Results

New Form 10-Q - INTEGRA LIFESCIENCES HOLDINGS CORP Filed: 2025-07-31 AccNo: 0000917520-25-000074 Size: 11 MB

New Form 10-Q - Spok Holdings, Inc Filed: 2025-07-31 AccNo: 0001289945-25-000044 Size: 5 MB

Orchestra BioMed Announces Proposed Public Offering